Pack a punch with Proteome
Buy Proteome Sciences (PRM:AIM) ahead of the fledgling biotech's maiden profit next year.Growth at the Cobham-based company has taken longer than expected to materialise. But adoption of the £74 million cap's protein biomarker...
08 November 2012